COSCIENS Biopharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $58.2M | $80.1M | $6.2M |
| FY2022 | $4.0M | $27.8M | $10.2M |
| FY2023 | $2.7M | $23.7M | $6.7M |
| FY2024 | $21.9M | $35.1M | $16.4M |
| FY2025 | $17.6M | $21.4M | $7.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $58.2M | $80.1M | $6.2M |
| FY2022 | $4.0M | $27.8M | $10.2M |
| FY2023 | $2.7M | $23.7M | $6.7M |
| FY2024 | $21.9M | $35.1M | $16.4M |
| FY2025 | $17.6M | $21.4M | $7.3M |